Frequently Asked Questions
The market is segmented based on , By Product Type (Implant and Stent, Glaucoma Drainage, Glaucoma Laser Device, Intraocular Lens, Opthalmic Viscoelastic Device, Phacoemulsification System), Surgery Type (Glaucoma in Conjunction with Cataract, Femtosecond Laser Surgery, Phacoemulsification, Extracapsular Cataract Extraction Surgery, Stand Alone Glaucoma), End-User (Hospitals, Outpatient Surgery Center, Ophthamology Clinic, Others) – Industry Trends and Forecast to 2030.
.
The Global Minimally Invasive Cataract Surgery Devices Market size was valued at USD 5.50 USD Billion in 2022.
The Global Minimally Invasive Cataract Surgery Devices Market is projected to grow at a CAGR of 30% during the forecast period of 2023 to 2030.
The major players operating in the market include Hoya Corporation, AbbVie , Essilor, NIDEK Co. , Lumenis Be , Abbott, Johnson & Johnson Services , New World Medical , Carl Zeiss Meditech AG, Alcon Vision LLC., Opcon USA, Bausch & Lomb orporated, STAAR SURGICAL.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
